MedPageToday
MedPage Today) — Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as compared with chemotherapy alone, according to final results from a large randomized trial.
Men with metastatic…
Read More
End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?
Johnathon Pingree
15:20
MedPage Today) — Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as compared with chemotherapy alone, according to final results from a large randomized trial. Men with metastatic…